How Gut Bacteria, Butyrate, and Omega-3s May Relate to Colorectal Cancer Risk
This scientific review looks at how bacteria living in the gut break down fiber into a compound called butyrate, one of several short-chain fatty acids. Butyrate is the preferred fuel source for cells lining the colon, and lab and animal studies suggest it may help support a healthy gut lining, reduce inflammation, and even trigger the natural die-off of abnormal cells.
The authors describe how an imbalance in gut bacteria (dysbiosis) has been linked to colorectal cancer risk in various studies, while a healthy population of butyrate-producing bacteria, such as Faecalibacterium prausnitzii and Roseburia species, has been associated with better gut barrier integrity and lower markers of inflammation.
The review also highlights research showing that higher dietary intake of omega-3 polyunsaturated fatty acids was associated with an increased density of butyrate-producing bacteria in the gut. Based on this connection, the authors propose that omega-3 PUFAs could be studied further as a dietary approach to help support healthy gut microbiota balance.
What this means for you
This review pulls together lab, animal, and early clinical research connecting gut bacteria, the fiber-derived compound butyrate, and colorectal cancer biology, and points out an interesting link between omega-3 intake and butyrate-producing bacteria. It does not show that omega-3 supplements prevent or treat colorectal cancer — it highlights a promising area for future research on diet and gut health.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.